1. The Definition of Failure in Hip Arthroscopy May Include Factors Outside of Reoperation: A Systematic Review
- Author
-
Christopher D. Bernard, M.D., Eva Bowles, M.D., Marcus Trotter, M.D., Levi Aldag, M.D., Erik Henkelman, M.D., Rachel Long, B.S., Paul Schroeppel, M.D., Scott Mullen, M.D., Jacob White, M.L.S., Armin Tarakemeh, B.A., and Bryan Vopat, M.D.
- Subjects
Sports medicine ,RC1200-1245 - Abstract
Purpose: To perform a systematic review about the varying definitions of “failure” of hip arthroscopy (HA) in the current literature and to provide a recommendation for the standardization of defining failure of HA. Methods: A systematic search of electronic databases was conducted to identity Level I-IV clinical studies on HA failure published between January 2016 and July 2021 according to Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Inclusion criteria consisted of studies of patients who underwent an arthroscopic hip procedure and included a definition of failure. Studies with patients who underwent open hip procedures and non–full-text articles were excluded. Results: Of 1,290 titles, 85 (6.6%) met inclusion criteria and were analyzed in this review. The most common definition of HA failure used was the need for any subsequent ipsilateral hip surgery (80/85, 94.1%). Among studies that noted reoperation as a cause for failure, conversion to total hip arthroplasty was most frequently cited (66/85, 77.6%) followed by any other reoperation on the ipsilateral hip, including repeat HA, hip resurfacing, and hip periacetabular osteotomy (65/85, 76.5%). Multiple studies used subjective patient-reported outcomes, with use of the modified Harris Hip Score being the most common (17/85, 20%). Conclusions: There are numerous definitions of the term “failure” of HA used by authors in the peer-reviewed literature. A standardized definition of HA failure should be multifactorial. It may include any unplanned subsequent procedures; patient-reported outcomes with emphasis on minimal clinically important difference, substantial clinical benefit, and/or patient acceptable symptom state values; and the inability to return to normal function or sports. Level of Evidence: Level IV, systematic review of Level III and IV studies.
- Published
- 2024
- Full Text
- View/download PDF